WO2012161489A3 - 리바스티그민 함유 패취 - Google Patents
리바스티그민 함유 패취 Download PDFInfo
- Publication number
- WO2012161489A3 WO2012161489A3 PCT/KR2012/003986 KR2012003986W WO2012161489A3 WO 2012161489 A3 WO2012161489 A3 WO 2012161489A3 KR 2012003986 W KR2012003986 W KR 2012003986W WO 2012161489 A3 WO2012161489 A3 WO 2012161489A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patch containing
- containing rivastigmine
- rivastigmine
- patch
- storage stability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12789117.4A EP2711002A4 (en) | 2011-05-20 | 2012-05-21 | PLASTER WITH RIVASTIGMIN |
US14/118,985 US9585862B2 (en) | 2011-05-20 | 2012-05-21 | Patch containing rivastigmine |
JP2014511305A JP6017543B2 (ja) | 2011-05-20 | 2012-05-21 | リバスティグミン含有パッチ |
BR112013029945A BR112013029945A2 (pt) | 2011-05-20 | 2012-05-21 | emplastro contendo rivastigmina |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110048068 | 2011-05-20 | ||
KR10-2011-0048068 | 2011-05-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012161489A2 WO2012161489A2 (ko) | 2012-11-29 |
WO2012161489A3 true WO2012161489A3 (ko) | 2013-01-17 |
Family
ID=47217881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/003986 WO2012161489A2 (ko) | 2011-05-20 | 2012-05-21 | 리바스티그민 함유 패취 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9585862B2 (ko) |
EP (1) | EP2711002A4 (ko) |
JP (1) | JP6017543B2 (ko) |
BR (1) | BR112013029945A2 (ko) |
WO (1) | WO2012161489A2 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140038237A (ko) * | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
CN103431846B (zh) * | 2013-09-18 | 2015-11-18 | 天津工业大学 | 智能睡眠监控系统 |
JP6100150B2 (ja) * | 2013-12-06 | 2017-03-22 | 久光製薬株式会社 | 4−アミノピリジン含有貼付剤 |
WO2015087927A1 (ja) * | 2013-12-12 | 2015-06-18 | 久光製薬株式会社 | カバー材付き貼付剤及びカバー材付き貼付剤キット |
US9949935B2 (en) | 2014-04-08 | 2018-04-24 | Teikoku Pharma Usa, Inc. | Rivastigmine transdermal compositions and methods of using the same |
JPWO2016052522A1 (ja) * | 2014-09-30 | 2017-07-27 | ニプロ株式会社 | 経皮投与製剤及び包装体 |
EP3233081B1 (en) * | 2014-12-19 | 2021-09-22 | Kindeva Drug Delivery L.P. | Transdermal drug delivery device including fentanyl |
JP6654365B2 (ja) * | 2015-06-17 | 2020-02-26 | 日東電工株式会社 | 貼付製剤 |
KR20200025883A (ko) * | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6335031B1 (en) * | 1998-01-12 | 2002-01-01 | Novartis Ag | TTS containing an antioxidant |
US20040258741A1 (en) * | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
WO2007064407A1 (en) * | 2005-12-01 | 2007-06-07 | Novartis Ag | Transdermal therapeutic system |
US20070259028A1 (en) * | 2006-05-08 | 2007-11-08 | Takeshi Ito | Percutaneous absorption preparations of antidementia drugs |
KR20100080681A (ko) * | 2009-01-02 | 2010-07-12 | 대화제약 주식회사 | 리바스티그민의 간단한 경피흡수제 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3615727A (en) * | 1967-03-23 | 1971-10-26 | Armin Starke | Method of preserving |
HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
JP5404048B2 (ja) | 2006-10-27 | 2014-01-29 | 久光製薬株式会社 | 貼付剤 |
US20100087768A1 (en) | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
EP2298277A1 (en) * | 2009-09-09 | 2011-03-23 | Labtec GmbH | Transdermal patch formulation |
WO2011049309A2 (ko) * | 2009-10-09 | 2011-04-28 | 영진약품공업 주식회사 | 속효성과 지속성을 동시에 갖는 약제학적 조성물 |
ES2670227T3 (es) * | 2009-12-22 | 2018-05-29 | Luye Pharma Ag | Sistema terapéutico transdérmico para la administración de rivastigmina o sus derivados |
KR101054317B1 (ko) * | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
-
2012
- 2012-05-21 US US14/118,985 patent/US9585862B2/en active Active
- 2012-05-21 WO PCT/KR2012/003986 patent/WO2012161489A2/ko active Application Filing
- 2012-05-21 BR BR112013029945A patent/BR112013029945A2/pt not_active IP Right Cessation
- 2012-05-21 JP JP2014511305A patent/JP6017543B2/ja not_active Expired - Fee Related
- 2012-05-21 EP EP12789117.4A patent/EP2711002A4/en not_active Ceased
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6335031B1 (en) * | 1998-01-12 | 2002-01-01 | Novartis Ag | TTS containing an antioxidant |
US20040258741A1 (en) * | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
WO2007064407A1 (en) * | 2005-12-01 | 2007-06-07 | Novartis Ag | Transdermal therapeutic system |
US20070259028A1 (en) * | 2006-05-08 | 2007-11-08 | Takeshi Ito | Percutaneous absorption preparations of antidementia drugs |
KR20100080681A (ko) * | 2009-01-02 | 2010-07-12 | 대화제약 주식회사 | 리바스티그민의 간단한 경피흡수제 |
Also Published As
Publication number | Publication date |
---|---|
US20140220104A1 (en) | 2014-08-07 |
WO2012161489A2 (ko) | 2012-11-29 |
JP6017543B2 (ja) | 2016-11-02 |
BR112013029945A2 (pt) | 2017-01-31 |
EP2711002A2 (en) | 2014-03-26 |
EP2711002A4 (en) | 2014-10-29 |
JP2014513719A (ja) | 2014-06-05 |
US9585862B2 (en) | 2017-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012161489A3 (ko) | 리바스티그민 함유 패취 | |
EP2756381A4 (en) | PAINTED ACTIVE LOCKING PAPERS | |
WO2012084126A3 (en) | Formulation of lacosamide | |
EP2566363A4 (en) | Footwear | |
HK1197242A1 (en) | Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines -56--4h-[13] | |
WO2014041560A3 (en) | Process for the preparation of teneligliptin | |
ZA201402759B (en) | Novel manganese comprising nanostructures | |
EP2529640A4 (en) | Buckle | |
WO2011091221A3 (en) | Manganese tetrathiotungstate material | |
EP2628085A4 (en) | Item level recovery | |
EP2898882A4 (en) | MEDICINAL PRODUCT WITH IMPROVED RIVASTIGMINE STABILITY | |
WO2014093305A3 (en) | Micrornas and uses thereof | |
EP2557348B8 (de) | Kondensatabscheider | |
AU2012902052A0 (en) | Storage Case | |
AU2011900272A0 (en) | Slope stability alarm | |
AU2011902012A0 (en) | Storage Case | |
AU2012101533A4 (en) | The Wheelie Fast | |
AU2011100252A4 (en) | Catch the Coasters | |
AU2010902333A0 (en) | Storage Case | |
AU2013205890A1 (en) | Storage tank | |
GB201117096D0 (en) | The one way shoelace | |
AU2010900440A0 (en) | The Tongue | |
AU2012903518A0 (en) | Improved Pullout Step | |
AU2012903370A0 (en) | Sneaker Savers | |
AU2011904403A0 (en) | The Ducks foot |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12789117 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2014511305 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012789117 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14118985 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013029945 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013029945 Country of ref document: BR Kind code of ref document: A2 Effective date: 20131121 |